HRT Financial’s MIRA Pharmaceuticals MIRA Stock Holding History

HRT Financial’s Portfolio MIRA Stock Details MIRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-30,651	Closed	-$33K	–	2747
2024 Q1	$33K	Buy	+30,651	New	+$33.3K	﹤0.01%	1973

Other funds holding MIRA

CSI

Cross Staff Investments Pittsford, New York $197M AUM 14.68% 1-Year Est. Return

APP

Avantax Planning Partners Dubuque, Iowa $3.64B AUM 14.73% 1-Year Est. Return

SEM

Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PWM

Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

FAB

First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

HRT Financial's MIRA Position: Q2 2024 in Review

HRT Financial sold out of MIRA Pharmaceuticals (MIRA) in Q2 2024, closing a stake of 30,651 shares — an estimated $33K sold.

HRT Financial first reported a position in MIRA in Q1 2024 and held it in 1 quarter. The position peaked at $33K in Q1 2024. 11 funds tracked by Wall St. Rank hold MIRA as of Q2 2024.

HRT Financial reported no remaining MIRA Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
HRT Financial sold 30,651 MIRA Pharmaceuticals shares in Q2 2024, an estimated $33K.
HRT Financial first reported a position in MIRA Pharmaceuticals in Q1 2024 and held it in 1 quarter.
HRT Financial's MIRA Pharmaceuticals position peaked at $33K in Q1 2024.
11 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.